Suppressing the growth of HL-60 acute myeloid leukemia cells by chitosan coated anthraquinone nanoparticles in vitro

References

• Mondal, S.; Bandyopadhyay, S.; Ghosh, M. K.; Mukhopadhyay, S.; Roy, S.; Mandal, C. Natural Products: promising Resources for Cancer Drug Discovery. Acamc. 2012, 12, 49–75.
   Google Scholar
• Nayak, B. S.; Bhaktha, G. Curcumin: A Wonder Anticancer Drug. Int. J. Pharm. Pharm. Sci. 2016, 8, 60–69.
   Google Scholar
• Kukreja, A.; Wadhwa, N.; Tiwari, A. Therapeutic Role of Resveratrol and Piceatannol in Disease Prevention. J. Blood. Disorders Transf. 2014, 5, 1–6.
   Google Scholar
• Lecumberri, E.; Dupertuis, Y. M.; Miralbell, R.; Pichard, C. Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) as Adjuvant in Cancer Therapy. Clin. Nutr. 2013, 32, 894–903.
   PubMed Web of Science ®Google Scholar
• Ramasamy, K.; Agarwal, R. Multitargeted Therapy of Cancer by silymarin. Cancer Lett. 2008, 269, 352–362.
   PubMed Web of Science ®Google Scholar
• Choudhuri, T.; Pal, S.; Das, T.; Sa, G. Curcumin Selectively Induces Apoptosis in Deregulated Cyclin D1-Expressed Cells at G2 Phase of Cell Cycle in a p53-Dependent Manner. J. Biol. Chem. 2005, 280, 20059–20068.
   PubMed Web of Science ®Google Scholar
• Weiss, R. B. The Anthracyclines: will We Ever Find a Better Doxorubicin? Semin. Oncol. 1992, 19, 670–686.
   PubMed Web of Science ®Google Scholar
• Huang, Q.; Lu, G.; Shen, H. M.; Chung, M. C.; Ong, C. N. Anti-Cancer Properties of Anthraquinones from Rhubarb. Med. Res. Rev. 2007, 27, 609–630.
   PubMed Web of Science ®Google Scholar
• Gewirtz, D. A. A Critical Evaluation of the Mechanisms of Action Proposed for the Antitumor Effects of the Anthracycline Antibiotics Adriamycin and Daunorubicin. Biochem. Pharmacol. 1999, 57, 727–741.
   PubMed Web of Science ®Google Scholar
• Minotti, G.; Menna, P.; Salvatorelli, E.; Cairo, G.; Gianni, L. Anthracyclines: molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity. Pharmacol. Rev. 2004, 56, 185–229.
   PubMed Web of Science ®Google Scholar
• Laurent, G.; Jaffrezou, J. P. Signaling Pathways Activated by Daunorubicin. Blood. 2001, 98, 913–924.
   PubMed Web of Science ®Google Scholar
• Xie, G.; Zhu, X.; Li, Q.; Gu, M.; He, Z.; Wu, J.; Li, J.; Lin, Y.; Li, M.; She, Z.; Yuan, J. SZ-685C, a Marine Anthraquinone, Is a Potent Inducer of Apoptosis with Anticancer Activity by Suppression of the Akt/FOXO Pathway. Br. J. Pharmacol. 2010, 159, 689–697.
   PubMed Web of Science ®Google Scholar
• Martı́n, D.; Salinas, M.; Fujita, N.; Tsuruo, T.; Cuadrado, A. Species Generated by H2O2 Induce Caspase-3-Independent Degradation of Akt/Protein Kinase. J. Biol. Chem. 2002, 277, 42943–42952.
   PubMed Web of Science ®Google Scholar
• Clementi, M. E.; Giardina, B.; DiStasio, E.; Mordente, A.; Misiti, F. Doxorubicin-Derived Metabolites Induce Release of Cytochrome C and Inhibition of Respiration on Cardiac Isolated Mitochondria. Anticancer Res. 2003, 23, 2445–2450.
   PubMed Web of Science ®Google Scholar
• Perchellet, E. M.; Wang, Y.; Weber, R. L.; Sperfslage, B. J.; Lou, K.; Lou, K.; Crossland, J.; Hua, D. H.; Perchellet, J. P. Synthetic 1,4-Anthracenedione Analogs Induce Cytochrome c Release, Caspase-9, - 3, and -8 Activities, Poly(ADP-Ribose) Polymerase-1 Cleavage and Internucleosomal DNA Fragmentation in HL-60 Cells by a Mechanism Which Involves Caspase-2 Activation but Not Fas Signaling. Biochem. Pharmacol. 2004, 67, 523–537.
   PubMed Web of Science ®Google Scholar
• O’Brien, M. E. R.; Wigler, N.; Inbar, M.; Rosso, R.; Grischke, E.; Santoro, A.; Catane, R.; Kieback, D. G.; Tomczak, P.; Ackland, S. P.; et al. Reduced Cardiotoxicity and Comparable Efficacy in a Phase III Trial of Pegylated Liposomal Doxorubicin HCl (CAELYX_/Doxil_) versus Conventional Doxorubicin for First-Line Treatment of Metastatic Breast Cancer. Annals of Oncol. 2004, 15, 440–449.
   PubMed Web of Science ®Google Scholar
• Zhang, C.; Wang, W.; Liu, T.; Wu, Y.; Guo, H.; Wang, P.; Tian, Q.; Wang, Y.; Yuan, Z. Doxorubicin-Loaded Glycyrrhetinic Acid-Modified Alginate Nanoparticles for Liver Tumor Chemotherapy. Biomaterials. 2012, 33, 2187–2196.
   PubMed Web of Science ®Google Scholar
• De Jong, W. H.; Borm, P. J. A. Drug Delivery and nanoparticles:applications and hazards. Int. J. Nanomedicine. 2008, 3, 133–149.
   PubMed Web of Science ®Google Scholar
• Soppimath, K. S.; Aminabhavi, T. M.; Kulkarni, A. R.; Rudzinski, W. E. Biodegradable Polymeric Nanoparticles as Drug Delivery Devices. J. Control. Release. 2001, 70, 1–20.
   PubMed Web of Science ®Google Scholar
• Coviello, T.; Matricardi, P.; Marianecci, C.; Alhaique, F. Polysaccharide Hydrogels for Modified Release Formulations. J Control Release. 2007, 119, 5–24.
   PubMed Web of Science ®Google Scholar
• Liu, Z.; Jiao, Y.; Wang, Y.; Zhou, C.; Zhang, Z. Polysaccharides-Based Nanoparticles as Drug Delivery Systems. Adv. Drug Deliv. Rev. 2008, 60, 1650–1662.
   PubMed Web of Science ®Google Scholar
• Murata, Y.; Jinno, D.; Liu, D.; Isobe, T.; Kofuji, K.; Kawashima, S. The Drug Release Profile from Calcium-Induced Alginate Gel Beads Coated with an Alginate Hydrolysate. Molecules. 2007, 12, 2559–2566.
   PubMed Web of Science ®Google Scholar
• Li, P.; Dai, Y. N.; Zhang, J. P.; Wang, A. Q.; Wei, Q. Chitosan-Alginate Nanoparticles as a Novel Drug Delivery System for Nifedipine. Int. J. Biomed. Sci. 2008, 4, 221–228.
   PubMedGoogle Scholar
• Pillai, C. K. S.; Paul, W.; Sharma, C. P. Chitin and Chitosan Polymers: chemistry, Solubility and Fiber Formation. Prog. Polym. Sci. 2009, 34, 641–678.
   Web of Science ®Google Scholar
• Khoushab, F.; Yamabhai, M. Chitin Research Revisited. Mar. Drugs. 2010, 8, 1988–2012.
   PubMed Web of Science ®Google Scholar
• Kean, T.; Thanou, M. Biodegradation, Biodistribution and Toxicity of Chitosan. Adv. Drug Deliv. Rev. 2010, 62, 3–11.
   PubMed Web of Science ®Google Scholar
• Gåserød, O.; Jolliffe, I. G.; Hampson, F. C.; Dettmar, P. W.; Skjåk-Braek, G. The Enhancement of the Bioadhesive Properties of Calcium Alginate Gel Beads by Coating with Chitosan. Int. J. Pharm. 1998, 175, 237–246.
   Web of Science ®Google Scholar
• George, M.; Abraham, T. E. Polyionic Hydrocolloids for the Intestinal Delivery of Protein Drugs: alginate and Chitosan-a Review. J. Control. Release. 2006, 114, 1–14.
   PubMed Web of Science ®Google Scholar
• Samarakoon, S. R.; Thabrew, I.; Galhena, P. B.; De Silva, D.; Tennekoon, K. A Comparison of the Cytotoxic Potential of Standardized Aqueous and Ethanolic Extracts of a Polyherbal Mixture Comprised of Nigella Sativa (Seeds), Hemidesmus Indicus (Roots) and Smilax Glabra (Rhizome). Phcog. Res. 2010, 2, 335–342.
   Google Scholar
• Joanna, W.; Malgorzata, K.; Andrej, H.; Ludumila, W. G. In Vitro Evaluation of Antiproliferative and Cytotoxic Properties of Pterostilbene against Human Colon Cancer Cells. Acta. Pol. Pharm. 2014, 71, 1051–1055.
   PubMed Web of Science ®Google Scholar
• Liu, K.; Liu, P.; Liu, R.; Wu, X. Dual AO/EB Staining to Detect Apoptosis in Osteosarcoma Cells Compared with Flow Cytometry. Med. Sci. Monit. Basic. Res. 2015, 21, 15–20.
   PubMed Web of Science ®Google Scholar
• Gopinath, P.; Gogoi, S. K.; Chattopadhyay, A.; Ghosh, S. S. Implications of Silver Nanoparticle Induced Cell Apoptosis for in Vitro Gene Therapy. Nanotechnology. 2008, 19, 075104
   PubMed Web of Science ®Google Scholar
• Nunez, R. DNA Measurement and Cell Cycle Analysis by Flow cytometry. Curr. Issues Mol. Biol. 2001, 3, 67–70.
   PubMedGoogle Scholar
• Selvaraj, S.; Saravanakumar, N.; Karthikeyan, J.; Deborah, E. D.; Lathamary, R. N. N. Acyclovir Loaded. Chitosan Nanoparticles for Ocular Delivery. Asian J. Pharm. 2010, 4, 220–431.
   Google Scholar
• Govender, T.; Stolnik, S.; Garnett, M. C.; Illum, L.; Davis, S. PLGA Nanoparticles Prepared by Nanoprecipitation: drug Loading and Release Studies of a Water Soluble Drug. J Control Release. 1999, 57, 171–185.
   PubMed Web of Science ®Google Scholar
• Yokoyama, M.; Satoh, A.; Sakurai, Y.; Okano, T.; Matsumura, Y.; Kakizoe, T.; Kataoka, K. J. Incorporation of Water-Insoluble Anticancer Drug into Polymeric Micelles and Control of Their Particle Size. J. Control Rel. 1998, 55, 219–229.
   PubMed Web of Science ®Google Scholar
• Kok, Y. J.; Swe, M.; Sit, K. H. Necrosis Has Orderly DNA Fragmentations. Biochem. Biophys. Res. Commun. 2002, 294, 934.
   PubMed Web of Science ®Google Scholar
• Ward, T. H.; Cummings, J.; Dean, E.; Greystoke, A.; Hou, J. M.; Backen, A.; Ranson, M.; Dive, C. Biomarkers of apoptosis. Br. J. Cancer. 2008, 99, 841–846.
   PubMed Web of Science ®Google Scholar
• Nesslany, F.; Simar-Meintieres, S.; Ficheux, H.; Marzin, D. Aloe-Emodin-Induced DNA Fragmentation in the Mouse in Vivo Comet Assay. Mutat. Res. 2009, 678, 13–19.
   PubMed Web of Science ®Google Scholar
• Kono, T.; Watanabe, M.; Koyama, K.; Kishimoto, T.; Fukushima, S.; Sugimura, T.; Wakabayashi, K. Cytotoxic Activity of Pierisin, from the Cabbage Butterfly, Pieris Rapae, in Various Human Cancer Cell Lines. Cancer Lett. 1999, 137, 75–81.
   PubMed Web of Science ®Google Scholar
• Bicknell, G. R.; Cohen, G. M. Cleavage of DNA to Large Kilobase Pair Fragments Occurs in Some Forms of Necrosis as Well as Apoptosis. Biochem. Biophys. Res. Commun. 1995, 207, 40–47.
   PubMed Web of Science ®Google Scholar
• Yan, B.; Wang, H.; Li, F.; Li, C. Y. Regulation of Mammalian Horizontal Gene Transfer by Apoptotic DNA Fragmentation. Br. J. Cancer. 2006, 95, 1696–1700.
   PubMed Web of Science ®Google Scholar
• Pietenpol, J. A.; Stewart, Z. A. Cell Cycle Checkpoint Signaling: cell Cycle Arrest versus Apoptosis. Toxicol. 2002, 181–182, 475–481.
   PubMed Web of Science ®Google Scholar
• Innocente, S. A.; Abrahamson, J. L.; Cogswell, J. P.; Lee, J. M. p53 Regulates a G2 Checkpoint through Cyclin B1. Proc. Natl. Acad. Sci. 1999, 96, 2147–2152.
   PubMed Web of Science ®Google Scholar
• Sa, G.; Das, T. Anti Cancer Effects of Curcumin: Cycle of Life and Death. Cell Div. 2008, 3, 14.
   PubMed Web of Science ®Google Scholar